Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Brand
Brand / product

Taripharm

Ofloxacin · 400 mg

ShareSend this page
Official DRAP price PKR 291.27 1x10's
PKR 29.13 / tablet
✓ DRAP listed · Verified 2026-08-09
Unit-price intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unit
Lowest unit pricePKR 27.70/ tablet
Unit-price rangePKR 27.70–30.98/ tablet
Comparable alternatives5current-price listings
This brandPKR 29.13 / tablet
5.2% above lowest unit price
Low
High
Compare equivalent brands 6 comparable presentations
BrandCompanyPackOfficial pack priceUnit price
Dixico NAVEGAL LABORATORIES 10 PKR 276.99 PKR 27.70/ tablet
Emevid Hoover Pharmaceuticals (Pvt.) Ltd 10's PKR 285.12 PKR 28.51/ tablet
OxoPulse Pulse Pharmaceuticals (Pvt.) Ltd. 10's PKR 286.23 PKR 28.62/ tablet
Taripharm This brand Epharm Laboratories 1x10's PKR 291.27 PKR 29.13/ tablet
MYOBID Panacea Pharmaceuticals 10 PKR 295.21 PKR 29.52/ tablet
Floxicon Amarant Pharmaceuticals Private Limited 10’s PKR 309.80 PKR 30.98/ tablet

Comparison is calculated from current listed prices and normalized pack quantities. Products with a different strength, dosage form, or incompatible/ambiguous pack unit are excluded.

Product details

Generic
Ofloxacin
Therapeutic area
Anti-infectives
Drug class
Fluoroquinolone antibacterials
ATC
Strength
400 mg
Dosage form
Tablet
Pack
1x10's
Registration no.
048402
Verification
2026-08-09

Manufacturer

Epharm Laboratories

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 291.272025-07-012026-08-09DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.